Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...

Principles of Disease Surveillance

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of COVID-19 on Movement Disorders Patients in the Outpatient Setting.

Cureus·2026

Same author

Neuromodulation and Tremor Suppression in the Periphery.

JAMA neurology·2025

Same author

Ataxia.

Continuum (Minneapolis, Minn.)·2025

Same author

Suicidal Ideation in Spinocerebellar Ataxia.

The Journal of neuropsychiatry and clinical neurosciences·2025

Same author

SARA captures disparate progression and responsiveness in spinocerebellar ataxias.

Journal of neurology·2024

Same author

Fatigue Impacts Quality of Life in People with Spinocerebellar Ataxias.

Movement disorders clinical practice·2024

Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026

Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026

Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026

Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026

Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026

Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 21, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

Parkinson Disease.

Theresa A Zesiewicz

Continuum (Minneapolis, Minn.)

|July 30, 2019

Summary

This summary is machine-generated.

Parkinson disease is a complex neurodegenerative disorder with both motor and nonmotor symptoms. Advances in pharmacologic and surgical treatments offer improved management, though a cure remains elusive.

More Related Videos

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Related Experiment Videos

Last Updated: Jan 21, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Area of Science:

Neuroscience
Neurology

Background:

Parkinson disease affects millions globally, representing a significant public health challenge.
Recent decades have seen substantial progress in understanding Parkinson disease's etiology, pathogenesis, and treatment.

Observation:

Parkinson disease is characterized by heterogeneity, encompassing both motor and nonmotor symptoms.
The disease progresses through preclinical, prodromal, and clinical phases.
Newer medications offer enhanced administration ease, while surgical interventions are available for persistent motor symptoms.

Findings:

Significant advancements have been made in pharmacological treatments for Parkinson disease.
Innovative surgical therapies provide options for patients with refractory motor symptoms.
Current understanding highlights Parkinson disease as a multifaceted condition with complex pathophysiology.

Implications:

Ongoing research promises further breakthroughs in Parkinson disease management and potential therapies.
Improved treatment modalities enhance patient quality of life.
Continued investigation into Parkinson disease pathogenesis is crucial for developing effective interventions.